WVE
Wave Life Sciences Ltd.Company with tickers: WVE
CIK
1631574
CUSIP
Y95308105
Shares Outstanding
192,402,202
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $38,246,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $69,544,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| Research & Development | $47,440,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| Operating Income | $-31,298,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| Net Income | $-26,087,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| EPS (Basic) | $-0.13 | USD/shares | 2026-03-31 | 10-Q | 2026-04-28 |
| EPS (Diluted) | $-0.13 | USD/shares | 2026-03-31 | 10-Q | 2026-04-28 |